Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
BUZZ-Diamondback rises after $4.08 billion deal for Midland assets
** Shares of oil and natural gas company Diamondback Energy FANG.O rise 1.2% to $158.90 premarket** Co to buy certain units of Encap-backed energy producer Double Eagle in about $4.08 bln cash-and-stock deal** Co to pay $3 billion in cash and 6.9 million shares, and transaction is expected to close ...
Reuters
Tue, Feb 18
Axsome Therapeutics Revenue Surges 66%
Biopharmaceutical firm Axsome Therapeutics (NASDAQ:AXSM) reported mixed fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 18. The company achieved substantial revenue growth, with sales hitting $118.8 million, surpassing analyst estimates of $118 million. However, its adjusted earnings per...
The Motley Fool
Tue, Feb 18
The Trade Desk Stock Tumbles. Is AppLovin the Culprit?
Investors in The Trade Desk (NASDAQ: TTD) were seeing red on Thursday as the stock plunged, but they were also green with envy.As shares of The Trade Desk tumbled more than 30%, fellow adtech titan AppLovin (NASDAQ: APP) was soaring on its earnings report, jumping more than 20% on its fourth-quarter...
The Motley Fool
Tue, Feb 18
BUZZ-Morgan Stanley downgrades Hims and Hers to 'equal weight' after recent share run
** Morgan Stanley downgrades rating on telehealth firm Hims and Hers HIMS.N to "equal weight" from "overweight"** HIMS shares down marginally at $60.35 premarket ** "While HIMS checks a lot of boxes we evaluate for an investment thesis ... meaningful outperformance in the stock ...
Reuters
Tue, Feb 18
BUZZ-Teva rises as FDA accepts to review biosimilar to eye disease drug Eylea
** U.S.-listed shares of Israel-based drugmaker Teva Pharmaceutical Industries TEVA.TA, TEVA.N rises 6.6% to $17.32 premarket** TEVA and partner Biotech Alvotech ALVO.O say the U.S. FDA has accepted for review its marketing application for a biosimilar or close copy of Regeneron's REGN.O Eylea *...
Reuters
Tue, Feb 18
Yiren Digital Integrates DeepSeek to Boost Innovation and Operational Excellence
BEIJING, Feb. 18, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China, has officially integrated with DeepSeek, marking a significant milestone ...
PR Newswire
Tue, Feb 18
BUZZ-Bath & Body Works up after J.P.Morgan upgrades to 'overweight'
Updates** Shares of beauty and skincare firm Bath & Body Works BBWI.N rise ~4% to $37.98 premarket** Brokerage J.P.Morgan upgrades stock to "overweight" from "neutral" citing potential for revenue growth in FY25** Brokerage sees BBWI's "three-legged stool" of product ...
Reuters
Tue, Feb 18
Constellation Energy beats Q4 estimates, affirms 2025 guidance
Investing.com -- Constellation Energy Corporation reported fourth-quarter earnings that surpassed analyst expectations while also affirming its full-year 2025 guidance.The energy company posted adjust
Investing.com
Tue, Feb 18
BUZZ-Entergy rises after Q4 profit beat
** Shares of U.S.-based utility company Entergy ETR.N rise 2% to $84.20 premarket** Co's Q4 profit comes ahead of estimates, helped by lower operating expenses and higher electricity demand** Reports Q4 adj. profit of 66 cents vs est. of 64 cents - data compiled by LSEG** Forecasts 2025 adj. ear...
Reuters
Tue, Feb 18
Is Chevron an Undervalued Dividend Stock?
Chevron's (NYSE: CVX) business is booming, but the long-term viability remains the key.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »*Stock prices used were the afternoon prices of Feb. 13, 2025. The video was ...
The Motley Fool
Tue, Feb 18
Genuine Parts delivers mixed Q4 results, stock slightly higher
Investing.com -- Genuine Parts Co (NYSE:GPC) posted mixed results for the fourth quarter of fiscal 2024, missing earnings per share (EPS) expectations while generating better-than-expected revenue
Investing.com
Tue, Feb 18
BUZZ-Fluor falls after downbeat annual profit forecast, Q4 results; announces CEO transition
** Shares of construction firm Fluor FLR.N down 6.7% at $40.50 premarket** Company forecasts annual adjusted EPS between $2.25 and $2.75, compared with Street estimates of $2.95 - data compiled by LSEG** Also reports Q4 revenue rise of 11.5% to $4.26 billion, below estimates of $4.42 billion, while ...
Reuters
Tue, Feb 18
Investors Obsess Over This Metric for XRP, but Does It Actually Matter?
A widely watched coin like XRP (CRYPTO: XRP) is bound to be immersed in a constant discussion about every single one of its aspects and its relevant metrics.If you're thinking about investing in it, or if you're already holding it, you're doubtlessly exposed to this chatter. And whether you admit it...
The Motley Fool
Tue, Feb 18
Medtronic Q3 earnings beat estimates, revenue misses
Investing.com -- Medtronic plc reported third-quarter fiscal 2025 earnings that beat analyst estimates, while revenue fell short of expectations. The medical device maker reiterated its full-year guid
Investing.com
Tue, Feb 18
CORRECTED-GRAPHIC-What the German election means for markets
Corrects date in dateline to Feb 18, not Feb 19Germany holds snap poll on SundayDebt brake, weak economy, parliament seat numbers in focus Defence spending set for a boostBy Samuel Indyk, Greta Rosen Fondahn, Stefano Rebaudo LONDON, Feb 18 (Reuters) - Sunday's German election may result in a ...
Reuters
Tue, Feb 18
US STOCKS-Futures rise with Fed policy, trade tariffs in focus
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.Constellation Brands jumps after Berkshire discloses stakeIntel up after report Broadcom, TSMC eye deals to split itFutures up: Dow 0.11%, S&P 500 0.31%, Nasdaq 0.34%Updates prices througho...
Reuters
Tue, Feb 18
BUZZ-Arcus Biosciences falls on pricing $150 mln stock offering at 16% discount
** Arcus Biosciences shares RCUS.N drop 4% to $12.57 premarket** Arcus's 13.6 mln stock offering priced at $11 each, a 16% discount to last close** Co plans to use gross proceeds of ~$150 mln to develop its experimental kidney cancer drug and for other purposes** Goldman Sachs, Leerink Partners ...
Reuters
Tue, Feb 18
Prediction: 3 Reasons Donald Trump Can Expect a Big Move in Inflation in 2025
A faster-than-expected inflation rate for January spooked the stock market on Wednesday, with rising costs for food, shelter, and energy all combining to push inflation up to 3% for the year. Core inflation, which doesn't count two of those three factors, is actually running even hotter at 3.3% pres...
The Motley Fool
Tue, Feb 18
BUZZ-U.S. STOCKS ON THE MOVE-Intel, Constellation, Bath & Body Works
Eikon search string for individual stock moves: The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures rose on Tuesday as investors sought insight into the Federal Reserve's policy plans following a decline in Treasu...
Reuters
Tue, Feb 18
BUZZ-GeneDx jumps on fourth quarter revenue beat, strong forecast
** Medical device maker GeneDx's shares WGS.O surge 19.3% to $91.1 premarket ** Co posts Q4 revenue of $95.3 mln, beating analyst est of $82.23 mln as per data compiled by LSEG ** Co forecasts 2025 revenue in the range of $350 mln to $360 mln, higher than analysts' expectations of $338.8 mln...
Reuters
Tue, Feb 18
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free